{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-20",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "life_sustain_support_flag": "N",
      "gmp_exempt_flag": "N",
      "summary_malfunction_reporting": "Ineligible",
      "product_code": "SBG",
      "openfda": {
        "k_number": [
          "DEN230061",
          "K252051"
        ],
        "registration_number": [
          "3027562169"
        ],
        "fei_number": [
          "3027562169"
        ]
      },
      "review_panel": "NE",
      "medical_specialty": "NE",
      "device_name": "In Situ Polymerizing Peripheral Nerve Cap",
      "review_code": "",
      "unclassified_reason": "",
      "medical_specialty_description": "Neurology",
      "device_class": "2",
      "definition": "An in situ polymerizing peripheral nerve cap is a prescription use only device composed of precursor materials that polymerize when delivered to the end of a peripheral nerve to function as a physical barrier to the surrounding in vivo environment to reduce the risk of formation of a symptomatic neuroma.",
      "regulation_number": "882.5260",
      "implant_flag": "Y",
      "submission_type_id": "1"
    }
  ]
}